This article is available online at http://www.jlr.org breast cancer and/or tumorigenesis in reproductive tissues ( 3 ). The BRCA1 gene produces either a full-length breast cancer type 1 susceptibility protein (BRCA1) or through alternatively splicing two documented variants, BRCA1 ⌬ 11 or BRCA1 ⌬ 11b, both of which lack a nuclear localization signal ( 4 ). Recently, BRCA1 was identifi ed as a regulator of lipid metabolism in human breast cancer cells (MCF7) as a result of direct interaction with the phosphorylated form of acetylCoA carboxylase (ACC-p) at the BRCA1 C-terminal (BRCT) domains ( 5, 6 ). The interaction encourages the maintenance of the phosphorylated state of ACC thereby altering lipid metabolism in the cancer cell line ( 5, 6 ).
consent to participate. The mean (range) age, height, and weight were 26 (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) years, 177 (158-190) cm, and 75 (58-90) kg, respectively. The mean (range) maximal oxygen consumption (VO 2 max) was 48 ml·kg Ϫ 1 ·min Ϫ 1 . Well-trained subjects (VO 2 max > 65 ml·kg Ϫ 1 ·min Ϫ 1 ) were excluded to maximize the subjects' exercise responses ( 14 ) . Skeletal muscle biopsies from the vastus lateralis (VL) muscle were obtained using the percutaneous needle biopsy technique at rest (prior to the exercise bout) and at 30 min after the exercise bout, alternating between the legs . All biopsy samples were snap-frozen in liquid nitrogen and stored at Ϫ 80°C until further analysis.
Mouse mRNA analysis
Isolation of RNA and subsequent cDNA synthesis from the gastrocnemius or plantaris muscles and mouse testes (positive control) was performed according to the previously described techniques ( 15, 16 ) . Specifi c primers for mouse Brca1 were as follows: forward 5 ′ -CAC AGC GTA TGC CAG AGA AA-3 ′ and reverse 5 ′ -ATC CTG GGA GTT TGC ATT TG-3 ′ .
Human mRNA analysis
Total RNA from the skeletal muscle biopsies was isolated using standard methods ( 17 ) and real-time RT-PCR was used to measure two short BRCA1 splice variants ( BRCA1 ⌬ 11 , BRCA1 ⌬ 11b ) and total BRCA1 ( BRCA1 total). Amplicons were synthesized using previously described sequences ( 4 ) . GAPDH was used as an internal control (4352934E, Applied Biosystems Inc.). Primer effi ciency was tested with standard titration curves and did not differ between the primer pairs. The expression of each target was determined by the DeltaDelta Ct method ( 18 ) .
Homogenization
Mouse skeletal muscle was mechanically homogenized according to previously described techniques ( 15, 19 ) . Human skeletal muscle biopsies were homogenized on ice using glass-on-glass homogenizers in RIPA buffer [150 mM NaCl, 10 mM Tris-HCl, 5 mM EDTA, 0.5% Na deoxycholate, 0.1% SDS, 1% Triton X-100, and protein inhibitor cocktail complete mini (Roche Diagnostics)]. Total protein was determined in each sample using the Pierce BCA protein assay (mouse) or Bradford protein assay (human) as previously described ( 20, 21 ) .
BRCA1 immunoprecipitation
Immunoprecipitation of endogenous BRCA1 protein in mouse (500 g total protein) or human (150 g total protein) skeletal muscle homogenate was performed with 2 g BRCA1 antibody (I-20, sc-646; Santa Cruz Biotechnology, Santa Cruz, CA) and incubated, rocking, overnight at 4°C. The antigen-antibody complex was combined with protein A affi nity and then washed through repeated centrifugation steps. After the fi nal wash the pellet was suspended in sample buffer and heated to 100°C for 5 min. The sample was then cooled and the eluted protein was loaded onto an SDS-PAGE gel for Western blot analysis.
Immunoblotting analysis
Immunoblotting for either BRCA1 immunoprecipitation solution or whole muscle homogenate protein was performed as previously described ( 15, 20, 22 ) . Membranes were probed with an antibody specifi c for BRCA1 (I-20 or D-20, 1:200; Santa Cruz Biotechnology), ACC-p or ACC total (1:1,000; Cell Signal, Boston, MA), Akt-p or Akt total (1:1,000; Cell Signal), ␣ -actinin (1:5,000; Sigma-Aldrich, Saint Louis, MO), red fl uorescent protein (RFP) (1:2,000; Thermo Scientifi c, Waltham, MA). MCF7 cell lysates or mammary gland tissue from BRCA1 KO mice (BRCA1 MG KO) were used as a positive or negative control, respectively. BRCA1 MG KO lysates also served as a positive control to detect the In response to increased energetic demand, such as during exercise, skeletal muscle increases fatty acid entry into the mitochondria through CPT-1-mediated transport ( 12 ) . During acute exercise, this rate is enhanced in muscle by a reduction in MaCoA content due to reduced ACC activity ( 10 ) , with the inhibition of ACC mediated by AMP-activated protein kinase (AMPK) ( 9 ) . Because regular exercise is known to promote metabolic health, multiple investigations have targeted this metabolic mechanism in an effort to treat metabolic disease. ACC function is critical to the regulation of lipid metabolism in skeletal muscle because genetic ablation of ACC results in higher basal and insulin-stimulated palmitate oxidation rates ( 7 ) . Collectively, these results indicate that ACC plays an important role in skeletal muscle metabolism; however, key regulators of ACC remain unidentifi ed.
A previous investigation has shown BRCA1 mRNA is expressed in C2C12 myoblasts, which would suggest a possible role in skeletal muscle ( 13 ) . However, to our knowledge, no studies have mechanistically examined the role of BRCA1 in skeletal muscle. Thus, the purpose of this investigation was to establish whether BRCA1 was expressed in skeletal muscle and determine whether it acts as a regulator of metabolic function. Using an integrative and translational approach, we have identifi ed that BRCA1 is expressed in both mouse and human skeletal muscle. Our data indicate that BRCA1 infl uences mitochondrial function, lipid storage, and insulin responses in the skeletal muscle cell. Overall, the results indicate that BRCA1 function extends beyond reproductive tissues, suggesting that broader roles across multiple tissues should be evaluated.
MATERIALS AND METHODS

Animals
The University of Maryland Institutional Animal Care and Use Committee Review Board approved all aspects involving animal research. Male and female C57Bl/6 mice ranging from 8 to 10 weeks of age were utilized in this study. C57Bl/6 mice were divided into two groups, an exercise group (male, n = 6; female, n = 7) and a sedentary group (male, n = 6; female, n = 7). All animals were treadmill acclimated and then only the exercise group was subjected to an acute bout of treadmill exercise (male: 21.92 ± 0.57 m/min, 40.1 ± 2.75 min, 5% incline; female: 26.57 ± 0.30 m/min, 36.5 ± 4.3 min, 5% incline) while the sedentary animals were placed on the treadmill in a stationary position for an equivalent time. The males were run at a lower speed to maintain similar relative intensities between the males and females. At the end of the exercise bout, animals were euthanized and skeletal muscle was harvested, snap-frozen in liquid nitrogen, and stored at Ϫ 80°C. For the high-fat diet (HFD) study, 12-week-old C57Bl/6 male mice (n = 4/group) were placed on a normal chow diet (NCD) (10% kcal fat; D12450K Research Diets) or a HFD (45% kcal fat; D12451 Research Diets) for 10 weeks. At the conclusion of 10 weeks, animals were euthanized and skeletal muscle was harvested, snap-frozen in liquid nitrogen, and stored at Ϫ 80°C. 535 nm emission) and RFP fl uorescence (556 nm excitation; 586 nm emission) measures were recorded using a BioTek Synergy plate reader (BioTek, Winooski, VT). All 2-NBDG measures were normalized to RFP values.
Human myotube insulin signaling
Scrambled-shRNA-or shRNA-hBRCA1-treated human myotubes were serum starved for 4-5 h in DMEM. Myotubes were then either control treated or treated with 50 nM insulin for 30 min as previously described ( 32 ) . Protein was then isolated from control-treated or insulin-treated scrambled-shRNA or shRNAhBRCA1 human myotubes as previously described ( 33 ) .
Human myotube palmitate/oleate incubation and BODIPY imaging
shRNA-hBRCA1-or scrambled-shRNA-treated human myotubes were incubated in 30 M BSA-conjugated palmitate/oleate mixture in DMEM for 4 h as previously described ( 34 ) . Myotubes were then stained with BODIPY (Molecular Probes, Carlsbad CA) as previously described ( 35 ) . Myotubes were imaged with a Zeiss Axiovision 4 (Zeiss, Oberkochen, Germany) as previously described ( 34, 36 ) .
Human myotube reactive oxygen species (ROS) measures and imaging
Scrambled-shRNA-or shRNA-hBRCA1-treated human myotubes were placed in 2 ′ ,7 ′ -dichlorofl uorescein (DCF)-supplemented Krebs Ringer buffer for 30 min at 37°C and then washed three times. H2-DCF was quantifi ed using a fl uorescent plate reader (H2; Biotek, Burlington, VT). The myotubes were also visually imaged using an inverted epifl uorescence microscope (Zeiss).
Statistical analysis
All data are represented as the mean ± SEM. Statistical analysis was conducted using ANOVA or t -test (paired and unpaired) approaches with Tukey post hoc tests employed when appropriate. P р 0.05 was considered signifi cant.
RESULTS
Brca1 expression in mouse skeletal muscle
In mouse skeletal muscle, Brca1 mRNA and Brca1 protein were detectable ( Fig. 1A, B ). In addition, using standard immunoblotting or immunoprecipitation approaches with different antibodies specifi c to either the N-or Cterminal region, we consistently detected Brca1 (220 kDa) in whole muscle homogenates ( Fig. 1B, C ) . The resulting protein mass is consistent with previously published data concerning BRCA1 in other tissues ( 2, 6, 37 ) .
In reproductive tissue, Brca1 is an estrogen-sensitive gene ( 13, 38 ) , however, in the gastrocnemius muscle of mice we detected greater levels of both the full-length and short [Brca1 ⌬ 11, 85 kDa as previously defi ned ( 26 )] Brca1 splice variants in males compared with females ( Fig. 1D ) . Full-length Brca1 protein levels did not differ between gastrocnemius and tibialis anterior (TA) muscles within female or male mice, respectively ( Fig. 1E, F ) . Further, Brca1 protein was undetectable in the soleus muscle ( Fig. 1E, F ) . In female mice, no differences were detected in Brca1 ⌬ 11 protein content in the soleus, TA, or gastrocnemius muscle ( Fig. 1E ) . In contrast, in male mice, Brca1 ⌬ 11 was BRCA1 protein short splice variants ( BRCA1 ⌬ 11 , BRCA1 ⌬ 11b ) as previously described (23) (24) (25) (26) .
Nuclear and cytoplasmic fractions and BRCA1 immunoblotting
Nuclear and cytoplasmic fractions were prepared using a nuclear and cytoplasmic extraction kit (NE-PER® nuclear and cytoplasmic extraction reagents, 78833; Thermo Scientifi c) as previously described ( 27 ) . Purity and enrichment of nuclear fractions were demonstrated by measuring nuclear protein lamin A/C and the cytosolic protein ␤ -tubulin (T5201; Sigma-Aldrich) as previously described ( 28 ) .
Mouse MaCoA measures
MaCoA measures were performed on the gastrocnemius muscles from sedentary and acute exercise female and male mice as previously described ( 20 ) .
Human myoblast cell culture
Human skeletal muscle myoblasts and media were purchased from Zen-Bio (Research Triangle Park, NC). Human skeletal myoblasts were derived from the VL muscle biopsy from a healthy, lean (normal BMI), 24-year-old female and only used at low passage number (<7). Myoblasts were induced to differentiate to myotubes upon reaching ‫ف‬ 90% confl uence. All plates were visually examined to ensure that myotubes covered ‫ف‬ 90% of the well prior to any experimental utilization.
Adenovirus shRNA-hBRCA1 myotube infection
To reduce BRCA1 content in the human myotubes, the cells were transduced with either scrambled shRNA adenovirus (scrambled-shRNA) or adenovirus containing a shRNA sequence targeting the coding region of BRCA1 (nt.530-550_NM_007294) (shRNA-hBRCA1) and containing a RFP tag overnight (Vector Biolabs, Philadelphia, PA). Myotubes were then returned to regular growth media for 48 h and equivalent adenovirus infection was confi rmed via imaging detection of RFP. BRCA1 mRNA was isolated from adenovirus-infected human myotubes as previously described ( 29 ) . Reduction in BRCA1 mRNA expression was confi rmed in human myotubes 72 h post adenovirus infection using the same primers as above for BRCA1 total, BRCA1 ⌬ 11 , and BRCA1 ⌬ 11b.
Mitochondrial oxygen consumption
Mitochondrial oxygen consumption rates (OCRs) were measured in shRNA-hBRCA1-or scrambled-shRNA-treated human myotubes similar to our previously described technique ( 20, 30 ) . In parallel plates, ACC phosphorylation was assessed after 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) treatment in the same myotubes with either normal or reduced BRCA1 content.
Human myotube 2-NBDG insulin stimulated glucose uptake
Ad-shRNA-hBRCA1-RFP-or AD-shRNA-RFP-treated human myotubes were serum starved for 4-5 h as previously described ( 31 ) . Myotubes were then washed three times and incubated with or without 50 nM insulin in warm Krebs-Ringer solution (135 mM NaCl, 10 mM NaHCO 3 , 5 mM KCl, 3 mM CaCl 2 , 2 mM MgSO 4 , 1.2 mM NaH 2 PO 4 ) excluding glucose for ‫ف‬ 30 min at 37°C. At the conclusion of the insulin incubation, myotubes were exposed to 50 M 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucoseR (2-NBDG) with or without 50 nM insulin for ‫ف‬ 30 min at room temperature as previously described ( 31 ). Myotubes were then washed three times and placed in room temperature Krebs-Ringer solution and 2-NBDG fl uorescence (438 nm excitation; by guest, on October 14, 2017 www.jlr.org
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In response to the exercise bout there was a signifi cant increase in Brca1-Acc-p protein-protein interaction in both female and male gastrocnemius muscle compared with sedentary animals ( P < 0.05) ( Fig. 2D ). However, in females, the exercise-induced Brca1-Acc-p interaction tended to be greater than males ( P = 0.09) ( Fig. 2D ).
Brca1 mRNA expression is increased in skeletal muscle from mice on a HFD Adult mice exposed to a HFD (45% kcal fat) exhibited an increase in Brca1 mRNA in the plantaris muscle compared with age-matched mice on a NCD (10% kcal fat) ( Fig. 2E ) .
BRCA1 mRNA and BRCA1 protein expression in human skeletal muscle
In an effort to translate the observations found in our murine model, similar experiments were performed in signifi cantly higher in TA and soleus muscle compared with the gastrocnemius muscle ( P < 0.05) ( Fig. 1F ).
Brca1 and Acc-p complex after an acute exercise bout in mice
In order to assess the potential interaction between the endogenous forms of Acc-p and Brca1, mice were subjected to an acute bout of treadmill exercise. Exercise induced signifi cant elevations in the ratio of Acc-p/Acc total in both male and female gastrocnemius muscle compared with sedentary animals ( P < 0.05) ( Fig. 2A, B ) . As expected, MaCoA content signifi cantly decreased in response to the exercise bout in the female animals, but surprisingly the increase in Acc-p levels did not correspond to a decline in MaCoA levels in the male mice ( Fig. 2C ) . Further, MaCoA levels in sedentary female skeletal muscle were signifi cantly higher compared with sedentary males ( P < 0.05) ( Fig. 2C ) . No signifi cant differences were detected between male and female mice for Brca1 ⌬ 11 (78 kDa). Mammary gland from Brca1 KO mouse (MG KO) served as a negative control for full-length Brca1 and a positive control for the Brca1 splice variant (Brca1 ⌬ 11). E: No differences in Brca1 and Brca1 ⌬ 11 protein content in soleus, gastrocnemius (Gastroc), and TA muscles from adult female mice were detected. F: In skeletal muscle from adult male mice, no differences across muscle groups were detected in Brca1 protein content, while Brca1 ⌬ 11 content was signifi cantly higher in the TA and soleus compared with the gastrocnemius muscle. Total protein staining gels were used to ensure equal loading of protein across samples. Data are presented as mean ± SEM (n = 3 mice per group for Western blotting measures). * P < 0.05 female versus male; # P < 0.05 TA versus gastrocnemius; $ P < 0.05 TA versus soleus.
by guest, on October 14, 2017 www.jlr.org Downloaded from biopsies. The short splice variants (lacking nuclear localization signal, BRCA1 ⌬ 11, and BRCA1 ⌬ 11b) of BRCA1 were almost exclusively detected in the cytosolic fraction, whereas the full-length BRCA1 protein was predominantly detected in the nuclear fraction ( Fig. 3F ) . Although mRNA for BRCA1 ⌬ 11 and BRCA1 ⌬ 11b was individually detected, it was not possible to distinguish the protein products due to similar molecular masses.
BRCA1 and Acc-p complex after an acute exercise bout in humans
To assess the role of BRCA1 in skeletal muscle, women and men performed an acute bout of exercise. The exercise humans. BRCA1 mRNA (full-length and splice variants) was detected in human skeletal muscle, with no differences between sedentary women and men ( Fig. 3A ) . The two wellrecognized short variants in human tissue, BRCA1 ⌬ 11 and BRCA1 ⌬ 11b mRNA, were readily expressed in human skeletal muscle with no sex differences ( Fig. 3B, C ) . Using antibodies specifi c to the C-and N-terminal regions, the presence of BRCA1 protein in human skeletal muscle was verifi ed ( Fig. 3D ) , with no detectable sex differences ( Fig. 3E ) . Previous research has suggested that BRCA1 isoforms exhibit specifi c intracellular localization ( 4, 37 ) . Thus, BRCA1 protein content was measured in nuclear and cytosolic fractions from male and female skeletal muscle A-E: An acute bout of exercise increases endogenous Acc-p and Brca1 interaction in skeletal muscle in adult male and female mice. A, B: Acc-p levels were signifi cantly higher in response to an acute bout of exercise (Ex) in the gastrocnemius muscle from adult female and male mice compared with sedentary (Sed) mice. C: MaCoA levels were signifi cantly higher in gastrocnemius muscles from sedentary female mice compared with sedentary male mice. Adult female mice exposed to an acute bout of exercise had signifi cantly lower MaCoA levels compared with the female sedentary mice and no signifi cant differences were apparent in gastrocnemius muscle from male mice. D: Interaction between Brca1 and Acc-p was greater in gastrocnemius muscle from sedentary females compared with sedentary males. Brca1 and Acc-p interaction was signifi cantly higher after an acute bout of exercise in gastrocnemius muscles from both male and female mice when compared with their sedentary counterparts. Data are presented as mean ± SEM (n = 6-7 per group). * P < 0.05 sedentary versus exercise; # P < 0.05 male sedentary versus female sedentary; $ P = 0.09 male exercise versus female exercise. E: Changes in Brca1 mRNA in the plantaris muscle in age-matched C57Bl/6 female mice after 12 weeks of a NCD or a HFD. Data are presented as mean ± SEM (n = 4 per group). * P < 0.05 NCD versus HFD . IB, immunoblot; IP, immunoprecipitation. lipid storage compared with control myotubes (scrambledshRNA) ( Fig. 5B ) . When myotubes were treated with conjugated-FFA, we observed an additional increase in lipid storage in myotubes with reduced BRCA1 expression compared with treated control myotubes ( Fig. 5B ) . Myotubes with reduced BRCA1 expression exhibited reduced Akt phosphorylation in response to insulin treatment (50 nM for 30 min) compared with the insulin response in the control myotubes ( Fig. 5C ). Myotubes with reduced BRCA1 expression exhibited reduced insulin-induced glucose uptake compared with the control myotubes ( Fig. 5D ). There were no differences in basal glucose uptake responses between groups.
Reductions in BRCA1 expression results in decreased mitochondrial oxygen consumption in human myotubes
Human myotubes with reduced BRCA1 expression exhibited lower basal OCRs compared with scrambled-shRNA myotubes ( P < 0.05) ( Fig. 6A, B ) . Treatment of the myotubes with oligomycin resulted in reduced OCR with no bout resulted in a signifi cant increase in ACC-p/ACC total compared with pre-exercise values ( P < 0.05) ( Fig. 4A, B ) . There was considerable individual variability in the magnitude of interaction between ACC-p and BRCA1 in both males and females prior to and after the completion of the exercise bout ( Fig. 4C ) . There was no signifi cant difference across sex in the ACC-p and BRCA1 interaction, thus the data were collapsed across sex. In response to an acute bout of exercise, there was an increase in BRCA1 and ACC-p protein interaction when compared with the resting state ( Fig. 4D, E ) .
Reductions in BRCA1 expression results in accumulation of intramyocellular lipid and reduced insulin-induced glucose uptake
Infection of human myotubes with shRNA-hBRCA1 resulted in nearly undetectable BRCA1 mRNA expression compared with infection with scrambled-shRNA ( Fig. 5A ) . Loss of BRCA1 expression (shRNA-hBRCA1) in human myotubes resulted in accumulation of intracellular neutral Fig. 3 . A-F: BRCA1 expression is detectable in biopsies taken from human VL. A-C: No signifi cant differences were detected in mRNA expression of all recognized human BRCA1 variants in skeletal muscle biopsies taken from males and females. All data were normalized to GAPDH. D: The presence of BRCA1 protein in human skeletal muscle was verifi ed using antibodies specifi c to the C terminus (C-term) (Ab:1) or N terminus (N-term) (Ab:2). E: No signifi cant differences in BRCA1 protein were detected between men and women in biopsies from the VL. F: Full length BRCA1 was detected predominantly in the nuclear fraction isolated from the VL from men and women, whereas the BRCA1 ⌬ 11/ ⌬ 11 splice variant was detected in the cytoplasmic fraction. Cell lysates isolated from the mammary gland of BRCA1 KO animals were used as a positive control for the BRCA1 ⌬ 11/ ⌬ 11b splice variants. Laminin was used as a nuclear control protein and ␤ -tubulin as the cytoplasmic control protein. Data are presented as mean ± SEM (n = 13 per group for mRNA analysis; n = 5-6 per group for BRCA1 Western blot analysis).
by guest, on October 14, 2017 www.jlr.org Downloaded from of ACC ( ‫ف‬ 70% increase) suggesting that BRCA1 is not required for phosphorylation of ACC to occur ( P < 0.05). In addition, it is possible that the failure of AICAR to further increase ACC phosphorylation under the reduced BRCA1 conditions is due to hyper-phosphorylation of ACC under basal conditions ( Fig. 7A, B ) .
Loss of BRCA1 expression increases ROS production leading to AMPK phosphorylation
We assessed global ROS content in myotubes with or without BRCA1 . Using a global ROS indicator (H2-DCF) ( Fig. 8A-F ) , we found higher ROS content in myotubes transduced with shRNA-hBRCA1 compared with scrambled-shRNA-treated myotubes ( Fig. 8G ) .
DISCUSSION
BRCA1 is a large polyfunctional protein (220 kDa) that regulates a number of different intracellular functions through a variety of mechanisms including protein-protein differences detected in OCR values between groups (data not shown). Maximal OCR induced by uncoupling was also lower in shRNA-hBRCA1-treated compared with scrambledshRNA myotubes ( Fig. 6C ). Subsequent addition of palmitate also resulted in lower OCR values in shRNA-hBRCA1 myotubes compared with scrambled-shRNA myotubes ( Fig. 6D ) . No differences in mitochondrial ATP synthase content were detected between conditions ( Fig. 6E ) .
Reductions in BRCA1 expression results in reduced AICAR-induced phosphorylation of ACC in human myotubes
AICAR induces phosphorylation of ACC via activation of AMPK; thus we determined the ability of AICAR to induce phosphorylation of ACC under reduced BRCA1 conditions. ACC-p content did not increase after AICAR treatment of the human myotubes infected with shRNAhBRCA1 compared with scrambled-shRNA-treated myotubes ( Fig. 7A, B ) . However, reducing BRCA1 content resulted in a signifi cant increase in basal phosphorylation of AMPK ( ‫ف‬ 20% increase) and increased basal phosphorylation Genetic alteration in the BRCA1 sequence and/or alterations in BRCA1 expression are strongly correlated with risk of tumorigenesis in reproductive tissues ( 40 ) . However, a functional role involving BRCA1 in skeletal muscle has gone unrecognized even though Brca1 mRNA content is known to increase in differentiating C2C12 myoblasts ( 13 ) . Our data signifi cantly extend this initial observation by demonstrating that both the long and short BRCA1 isoforms are present at the mRNA and protein level in adult mouse skeletal muscle and in human skeletal muscle. In addition, we found that mice exposed to a HFD exhibited increased full-length Brca1 mRNA expression in the plantaris muscle compared with mice fed a NCD, suggesting that Brca1 expression is modulated by changes in nutrient exposure. Consistent with previous literature, the full-length BRCA1 protein, which has an intact nuclear localization sequence ( 4, 24 ) , was detected predominantly in the nuclear fraction interactions ( 39 ) . To date, BRCA1 has been predominantly recognized as a cell cycle regulator and a DNA damage repair protein in reproductive tissues ( 4, 39 ) . However, the data presented here provide evidence for a novel role for BRCA1 as a regulator of metabolic function in skeletal muscle of both mice and humans. Specifi cally, in response to an energetic stress (i.e., acute exercise) there is a significant increase in the interaction of BRCA1 with ACC-p. In addition, adult mice consuming a HFD exhibited significant increases in Brca1 mRNA expression compared with mice on a NCD. Reducing BRCA1 content in human myotubes resulted in increased lipid storage, decreased insulin signaling, reduced mitochondrial function, and enhanced ROS production. Overall, our observations provide evidence for a previously undescribed role for BRCA1 and lend support for more detailed examinations of the role of BRCA1 as a metabolic regulator in skeletal muscle. In a series of elegant experiments, BRCA1 was previously shown to directly bind to ACC-p in mammary tissue ( 5, 6 ) . ACC is a critical regulator of lipid metabolism, as it catalyzes the production of MaCoA in skeletal muscle ( 7, 9, 10 ) . MaCoA can act as a potent allosteric inhibitor of CPT-1 or can serve as a precursor for lipid synthesis ( 9, 43 ) , with the former being the likely mechanism for ACC regulation of lipid metabolism in skeletal muscle ( 10, 44 ) . In both mice and humans, we used an acute bout of exercise to energetically challenge the muscle to increase ACC-p content in skeletal muscle. The increase in ACC-p also resulted in increased interaction between BRCA1 and ACC-p. Further, our data in the mouse indicate differential Brca1/Acc-p interactions in females and males both at rest and in response to an acute bout of exercise, which was also associated with differing content of MaCoA in the same muscle. To the best of our knowledge, this is the fi rst of human skeletal muscle while the short splice variants, which lack a nuclear localization sequence ( 4 ), were detected in the cytosolic fraction. It is well-established that BRCA1 is an estrogen-sensitive gene ( 41 ); thus it was surprising to fi nd higher Brca1 and Brca1 ⌬ 11 content in male than in female mouse gastrocnemius muscle. However, this sex difference did not translate to human skeletal muscle, as neither BRCA1 mRNA nor BRCA1 protein content differed across sexes. Finally, few differences were detected across skeletal muscle groups in mouse Brca1 expression and protein content. In fact, only the male mice presented with signifi cant differences in BRCA1 ⌬ 11 across muscle groups with the TA and the soleus muscles having greater levels of BRCA1 ⌬ 11 compared with the gastrocnemius muscle. In male mice, most muscles, including the soleus muscle, are composed of a mixed phenotype ( 42 ) . Thus, it is unclear why TA and/or soleus muscle would have signifi cant differences in only BRCA1 ⌬ 11 ( 42 ) . Our data demonstrate that multiple recognized forms of BRCA1 are detectable at previous fi ndings in MCF7 cells that reductions in BRCA1 expression results in increased lipid storage ( 5 ) . BRCA1 localization within the cell remains controversial, however it is generally accepted that BRCA1 is found within the mitochondria ( 50, 51 ) . Further, recent data have demonstrated that deletion of BRCA1 in cardiac muscle results in lower expression of multiple genes associated with the mitochondria and reductions in fatty acid oxidation rates ( 52 ) . In addition, because ACC2 localizes to the mitochondria and can be bound by BRCA1, there is strong evidence to suggest that BRCA1 is associated with the mitochondria ( 5 ). Collectively, evidence suggests a role for BRCA1 in regulating mitochondrial function that is likely independent of ACC. BRCA1 is considered a poly-functional protein due to its ability to regulate diverse cellular mechanisms including DNA repair. The ability of BRCA1 to infl uence DNA repair may explain its role in the mitochondria because mitochondrial DNA is highly susceptible to DNA damage ( 53, 54 ) . Thus, it is possible that loss of BRCA1 leads to loss of genomic integrity in the mitochondria. However, this hypothesis remains untested to date.
Our results show that reduced BRCA1 expression resulted in increased oxidative stress, as evidenced by increased DCF signal accumulation. At this time it is unclear if this is due to increased production of ROS or due to reduced ability to buffer ROS accumulation. Our data are in agreement with previous work demonstrating that the loss of BRCA1 in nonmuscle cells results in the accumulation of ROS ( 52, 55 ). BRCA1 appears to regulate antioxidant gene expression, thus protecting macromolecules against oxidative damage through a complex interaction with NRF2 ( 55, 56 ) . Exposure to elevations in ROS levels in skeletal muscle contributes to dysfunction of a number of mechanisms, including dysregulation of insulin-induced glucose uptake and mitochondrial function ( 57, 58 ) .
Reduced BRCA1 expression in the human myotubes resulted in reduced insulin-induced glucose uptake and lower Akt phosphorylation compared with the control myotube response. Our data suggest that the metabolic dysfunction induced by acute BRCA1 reduction induces poor insulin responses in human skeletal muscle. At this time, it is unclear if loss of BRCA1 directly impacts insulin time a sex-based difference in skeletal muscle MaCoA content has been demonstrated. Reanalysis of data from a previous publication ( 45 ) where male and female mice were treated with AICAR demonstrated a similar fi nding. Specifi cally, female mice presented higher levels of resting MaCoA and a greater response to AICAR treatment than age-matched male mice. Due to limited sample amounts, we were unable to directly measure MaCoA content in the human samples to compare the BRCA1/ACC-p interaction in a quantitative fashion. Thus, at this point it is unclear if there was also a differential MaCoA response in our human samples, although acute bouts of exercise similar to the one performed here are known to reduce MaCoA content in human muscle ( 46 ) . However, it was very clear that the magnitude of increase in interaction between BRCA1 and ACC-p in response to the exercise bout in the human samples was highly variable. Such variability may be, in part, due to the large degree of genetic variation in BRCA1, which can result in altered protein function and/or expression ( 47 ) . ACC-p interacts with BRCA1 in the C-terminal region, specifi cally in the BRCT domains ( 48 ) . Although the BRCT domains in BRCA1 are conserved across species, the BRCT domains in the human BRCA1 gene contain the highest degree of genetic variation ( 49 ) . Because ACC-p binds to the BRCT domain within BRCA1, it is possible that specifi c sequence variation in this domain may contribute to variations in the degree of ACC function in humans. Further examination of this hypothesis will be necessary to determine if documented SNPs within the BRCT domains of BRCA1 are associated with the risk of development of metabolic disease in humans. However, to our knowledge no single nucleotide polymorphisms in the BRCA1 gene have been associated with metabolic disease in a genome-wide association study.
To determine whether BRCA1 plays a critical role in regulation of skeletal muscle metabolic function, we reduced BRCA1 expression through shRNA technology. Reducing BRCA1 content in human myotubes resulted in increased neutral lipid storage and resulted in a concurrent reduction in mitochondrial function in the myotubes. Thus, our results in skeletal muscle are in agreement with In summary, we have identifi ed that BRCA1 expression is an important regulator of multiple intracellular processes that may infl uence metabolic function in both mouse and human skeletal muscle. Future experiments are critical to more clearly delineate the mechanisms by which BRCA1 infl uences the intracellular functions of skeletal muscle. These fi ndings signifi cantly extend our understanding of BRCA1 physiology by considering mechanistic aspects outside of its classically known role in mammary tissue. Future studies will be necessary to examine the therapeutic potential of manipulating BRCA1 expression and/or function in skeletal muscle as a means to prevent the development of metabolic diseases. signaling or if the reduced insulin response is a consequence of other cellular defects. For example, decreased BRCA1 expression resulted in reduction of mitochondrial function, excess ROS accumulation, and elevated neutral lipid storage, all of which have been associated with the development of insulin resistance. Future experiments will be crucial to identify the role of BRCA1 in the skeletal muscle insulin-signaling pathway. At this time, reduced BRCA1 expression in myotubes leads to a measurable decline in metabolic function of cultured skeletal muscle. Our data suggest that reductions in BRCA1 expression could contribute to metabolic disease susceptibility, thus arguing for more detailed in vivo explorations of the function of BRCA1 in skeletal muscle.
This initial study of BRCA1 in skeletal muscle has raised additional questions regarding the regulation and function of BRCA1 in skeletal muscle that will be addressed in future studies by our laboratory. Specifi cally, loss of BRCA1 leads to accumulation of neutral lipid, however it is currently unclear if increased lipid droplet content can be completely explained by reduced mitochondrial function or if this is in response to increased rates of triacylglycerol esterifi cation. In addition, due to the number of intracellular changes that developed with the reduction in BRCA1 expression in the primary human myotubes, it was impossible to accurately determine if a reduction in the insulin response is due to a primary effect of BRCA1 reduction or a secondary effect as a consequence of lipid accumulation or ROS production. Finally, there were limitations in the number of measures that could be made with the human 
